Stem cell combo shows promise for Parkinson's in small trial
NCT ID NCT06142981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a combination of platelet-rich plasma (PRP) and stem cell therapy could help people with Parkinson's disease. Thirty patients aged 30–50 received three PRP injections over three months, followed by a booster dose after one year. Researchers measured changes in movement, mood, and quality of life using standard Parkinson's rating scales. The goal was to see if this regenerative medicine approach could ease symptoms, not cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REGENERATIVE MEDICINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
gull e Rukh
Lahore, Punjab Province, 54780, Pakistan